Potential Clinical and Economic Impact of Switching Branded Medications to Generics
Open Access
- 1 May 2017
- journal article
- review article
- Published by Wolters Kluwer Health in American Journal of Therapeutics
- Vol. 24 (3) , e278-e289
Abstract
Switching branded to generic medications has become a common cost-containment measure. Although this is an important objective for health care systems worldwide, the impact of this practice on patient outcomes needs to be carefully considered. We reviewed the literature summarizing the potential clinical and economic consequences of switching from branded to generic medications on patient outcomes. A literature search of peer-reviewed articles published 2003–2013 using key words of “generic switching” or “substitution” was conducted using PubMed, OvidSP, and ScienceDirect. Of 30 articles identified and reviewed, most were related to the diseases of the central nervous system, especially epilepsy. Based on our review, potential impacts of switching fell into 3 broad categories: patient attitudes and adherence, clinical and safety outcomes, and cost and resource utilization. Although in many cases generics may represent an appropriate alternative to branded products, this may not always be the case. Specifically, several studies suggested that switching may negatively impact medication adherence, whereas other studies found that generic switching was associated with poorer clinical outcomes and more adverse events. In some instances, switching accomplished cost savings but did so at increased total cost of care because of increased physician visits or hospitalizations. Although in many cases generics may represent an appropriate alternative, mandatory generic switching may lead to unintended consequences, especially in certain therapeutic areas. Although further study is warranted, based on our review, it may be medically justifiable for physicians and patients to retain the right to request the branded product in certain cases.Keywords
This publication has 51 references indexed in Scilit:
- Special challenges for drug adherence following generic substitution in Pakistani immigrants living in NorwayEuropean Journal of Clinical Pharmacology, 2010
- Norwegian patients on generic antihypertensive drugs: a qualitative study of their own experiencesEuropean Journal of Clinical Pharmacology, 2010
- Generic and therapeutic substitutions in the UK: are they a good thing?British Journal of Clinical Pharmacology, 2010
- Effectiveness, safety and cost of drug substitution in hypertensionBritish Journal of Clinical Pharmacology, 2010
- Patients’ Perceptions Of Generic MedicationsHealth Affairs, 2009
- A pharmaco-economic analysis of patients with schizophrenia switching to generic risperidone involving a possible compliance lossBMC Health Services Research, 2009
- Challenges of Treatment Adherence in Older Patients with Parkinson’s DiseaseDrugs & Aging, 2009
- Clinical Equivalence of Generic and Brand-Name Drugs Used in Cardiovascular DiseaseJAMA, 2008
- Customers’ and physicians’ opinions of and experiences with generic substitution during the first year in FinlandHealth Policy, 2007
- What do primary care patients think about generic drugs?Int. Journal of Clinical Pharmacology and Therapeutics, 2005